MétaCan
Menu
Back to cohort
Record W2979840360 · doi:10.1158/0008-5472.can-19-1840

Association of Genomic Domains in <i>BRCA1</i> and <i>BRCA2</i> with Prostate Cancer Risk and Aggressiveness

2019· article· en· W2979840360 on OpenAlexafffund
Vivek Patel, Evan L. Busch, Tara M. Friebel, Angel M. Cronin, Goska Leslie, Lesley McGuffog, Julian Adlard, Simona Agata, Bjarni A. Agnarsson, Munaza Ahmed, Kristiina Aittomäki, Elisa Alducci, Irene L. Andrulis, Aðalgeir Arason, Norbert Arnold, Grazia Artioli, Brita Arver, Bernd Auber, Jacopo Azzollini, Judith Balmañà, Rósa B. Barkardóttir, Daniel R. Barnes, Alicia Barroso, Daniel Barrowdale, Muriel Belotti, Javier Benı́tez, Birgitte Bertelsen, Marinus J. Blok, I. Bodrogi, Valérie Bonadona, Bernardo Bonanni, Davide Bondavalli, Susanne E. Boonen, Julika Borde, Åke Borg, Angela R. Bradbury, Angela Brady, Carole Brewer, Joan Brunet, Bruno Buecher, Saundra S. Buys, Santiago Cabezas-Camarero, Trinidad Caldés, Almuth Caliebe, Maria A. Caligo, Mariarosaria Calvello, Ian Campbell, Ileana Carnevali, Estela Carrasco, Tsun Leung Chan, Annie Chu, Wendy K. Chung, Kathleen Claes, GEMO Study Collaborators, EMBRACE Collaborators, Jackie Cook, Laura Cortesi, Fergus J. Couch, Mary B. Daly, Giuseppe Damante, Esther Darder, Rosemarie Davidson, Miguel de la Hoya, Lara Della Puppa, Joe Dennis, Orland Dı́ez, Yuan Chun Ding, Nina Ditsch, Susan M. Domchek, Alan Donaldson, Bernd Dworniczak, Douglas F. Easton, Rosalind A. Eeles, Hans Ehrencrona, Bent Ejlertsen, Christoph Engel, D. Gareth Evans, Laurence Faivre, Ulrike Faust, Lídia Feliubadaló, Lenka Foretová, Florentia Fostira, George Fountzilas, Debra Frost, Vanesa García‐Barberán, Pilar Garré, Marion Gauthier‐Villars, Lajos Géczi, Andrea Gehrig, Anne‐Marie Gerdes, Paul Gesta, Giuseppe Giannini, Gord Glendon, Andrew K. Godwin, David E. Goldgar, Mark H. Greene, Angelica M. Gutierrez‐Barrera, Eric Hahnen, Ute Hamann, Jan Hauke, Frans B.L. Hogervorst, Ellen Honisch, John L. Hopper, Peter J. Hulick, kConFab Investigators, Hebon Investigators, Louise Izatt, Agnes Jager, Paul A. James, Ramūnas Janavičius, Uffe Birk Jensen, Thomas D. Jensen, Oskar T. Johannsson, Esther M. John, Joseph Vijai, Eunyoung Kang, Karin Kast, Johanna I. Kiiski, Sung-Won Kim, Zisun Kim, Kwang‐Pil Ko, Irene Konstantopoulou, Gero Kramer, Lotte Krogh, Torben A. Kruse, Ava Kwong, Mirjam Larsen, Christine Lasset, Charlotte Kvist Lautrup, Conxi Lázaro, Jihyoun Lee, Jong Won Lee, Min Hyuk Lee, Johannes R. Lemke, Fabienne Lesueur, Annelie Liljegren, Annika Lindblom, Patricia Llovet, Adrià López‐Fernández, Irene López‐Perolio, Víctor Lorca, Jennifer T. Loud, Edmond S.K., Siranoush Manoukian, Véronique Mari, Lynn Martin, Laura Matricardi, Noura Mebirouk, Veronica Medici, Hanne Meijers‐Heijboer, Alfons Meindl, Arjen R. Mensenkamp, Clare Miller, D. Molina Gomes, Marco Montagna, Thea M. Mooij, Lidia Moserle, Emmanuelle Mouret‐Fourme, Anna Marie Mulligan, Katherine L. Nathanson, Marie Navrátilová, Heli Nevanlinna, Dieter Niederacher, Finn C. Nielsen, Liene Ņikitina-Zaķe, Kenneth Offit, Edith Oláh, Olufunmilayo I. Olopade, Kai-Ren Ong, Ana Osório, Claus‐Eric Ott, Domenico Palli, Sue K. Park, Michael T. Parsons, Inge Søkilde Pedersen, Bernard Peissel, Ana Peixoto, Pedro Pérez‐Segura, Paolo Peterlongo, Annabeth Høgh Petersen, Mary Porteous, Miguel Ángel Pujana, Paolo Radice, Juliane Ramser, Johanna Rantala, Muhammad Usman Rashid, Kerstin Rhiem, Piera Rizzolo, Mark E. Robson, Matti A. Rookus, Caroline Maria Rossing, Kathryn J. Ruddy, Catarina Santos, Claire Saule, Rosa Scarpitta, Rita K. Schmutzler, Hélène Schuster, Leigha Senter, Caroline Seynaeve, Payal D. Shah, Priyanka Sharma, Vivian Y. Shin, Valentina Silvestri, Jacques Simard, Christian F. Singer, Anne‐Bine Skytte, Katie Snape, Ángela R. Solano, Penny Soucy, Melissa C. Southey, Amanda B. Spurdle, Linda Steele, Doris Steinemann, Dominique Stoppa‐Lyonnet, Agostina Stradella, Lone Sunde, Christian Sutter, Yen Y. Tan, Manuel R. Teixeira, Soo‐Hwang Teo, Mads Thomassen, Maria Grazia Tibiletti, Marc Tischkowitz, Silvia Tognazzo, Amanda Ewart Toland, Stefania Tommasi, Diana Torres, Angela Toss, Alison H. Trainer, Nadine Tung, Christi J. van Asperen, Frederieke H. van der Baan, Lizet E. van der Kolk, Rob B. van der Luijt, Liselotte P. van Hest, Liliana Varesco, Raymonda Varon-Mateeva, Alessandra Viel, Jeroen Vierstraete, Roberta Villa, Anna von Wachenfeldt, Philipp Wagner, Shan Wang‐Gohrke, Barbara Wappenschmidt, Jeffrey N. Weitzel, Greet Wieme, Siddhartha Yadav, Drakoulis Yannoukakos, Sook‐Yee Yoon, Cristina Zanzottera, Kristin K. Zorn, Anthony V. D’Amico, Matthew L. Freedman, Mark M. Pomerantz, Georgia Chenevix‐Trench, Antonis C. Antoniou, Susan L. Neuhausen, Laura Ottini, Henriette Roed Nielsen, Timothy R. Rebbeck

Bibliographic record

VenueCancer Research · 2019
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBRCA gene mutations in cancer
Canadian institutionsUniversity Health NetworkCentre hospitalier universitaire de QuébecAmgen (Canada)Lunenfeld-Tanenbaum Research InstituteUniversity of Toronto
FundersJonsson Comprehensive Cancer CenterNational Center for Advancing Translational SciencesEuropean Regional Development FundCanadian Institutes of Health Researchlékařská fakulta Univerzity KarlovyUniversity of California, San FranciscoNational Institutes of HealthKerry Group Kuok FoundationFreistaat SachsenCentro de Investigación Biomédica en Red de CáncerFox Chase Cancer CenterMinistero dello Sviluppo EconomicoFondazione Italiana per la Ricerca sul CancroMedical Research CouncilUppsala UniversitetNational Institute of General Medical SciencesInstitut National Du CancerAalborg UniversitetshospitalDeutsche KrebshilfeSahlgrenska UniversitetssjukhusetAssociazione Italiana per la Ricerca sul CancroKWF KankerbestrijdingLietuvos Mokslo TarybaOvarian Cancer Research FundMinisterio de Economía y CompetitividadLandspítali HáskólasjúkrahúsCancer Association of South AfricaKarolinska InstitutetLinköpings UniversitetHungarian Scientific Research FundNederlandse Organisatie voor Wetenschappelijk OnderzoekMinistero della SaluteGeneralitat de CatalunyaSeoul National UniversityNational Breast Cancer FoundationEuropean CommissionNational Institute for Health and Care ResearchU.S. Department of DefenseCancer Research UKGovernment of CanadaNational Cancer InstituteLiga Portuguesa Contra o CancroHospital de Câncer de BarretosIsrael Cancer AssociationInstitut Català de la SalutUniversity of PennsylvaniaFundación Mutua MadrileñaMinistère du Développement Économique, de l’Innovation et de l’ExportationAalborg UniversitetGenome CanadaBreast Cancer Research FoundationMcGill UniversityUniverzita Karlova v PrazeClalit Health ServicesDeutsches KrebsforschungszentrumAmerican Cancer SocietyFonds Wetenschappelijk OnderzoekCancer Center, University of KansasCancerfondenNRG OncologyFondation du cancer du sein du QuébecMemorial Sloan-Kettering Cancer CenterQIMR Berghofer Medical Research InstituteMinistério da Ciência, Tecnologia e InovaçãoDr. Ralph and Marian Falk Medical Research TrustEuropean Social FundUniversity of ChicagoCancer Research InstituteKansas Bioscience AuthorityInstituto de Salud Carlos IIIOhio State UniversityNational Health and Medical Research CouncilJewish General HospitalFisher Center for Alzheimer's Research FoundationCancer AustraliaGeorgetown UniversityCollege of Medicine, Seoul National UniversitySusan G. Komen for the CureBeth Israel Deaconess Medical CenterIstituto Oncologico VenetoUmeå UniversitetRoyal Marsden NHS Foundation Trust
KeywordsProstate cancerCancerOncologyMedicineBRCA2 ProteinGynecologyProstateInternal medicineBiologyGeneticsGeneMutation

Abstract

fetched live from OpenAlex

Abstract Pathogenic sequence variants (PSV) in BRCA1 or BRCA2 (BRCA1/2) are associated with increased risk and severity of prostate cancer. We evaluated whether PSVs in BRCA1/2 were associated with risk of overall prostate cancer or high grade (Gleason 8+) prostate cancer using an international sample of 65 BRCA1 and 171 BRCA2 male PSV carriers with prostate cancer, and 3,388 BRCA1 and 2,880 BRCA2 male PSV carriers without prostate cancer. PSVs in the 3′ region of BRCA2 (c.7914+) were significantly associated with elevated risk of prostate cancer compared with reference bin c.1001-c.7913 [HR = 1.78; 95% confidence interval (CI), 1.25–2.52; P = 0.001], as well as elevated risk of Gleason 8+ prostate cancer (HR = 3.11; 95% CI, 1.63–5.95; P = 0.001). c.756-c.1000 was also associated with elevated prostate cancer risk (HR = 2.83; 95% CI, 1.71–4.68; P = 0.00004) and elevated risk of Gleason 8+ prostate cancer (HR = 4.95; 95% CI, 2.12–11.54; P = 0.0002). No genotype–phenotype associations were detected for PSVs in BRCA1. These results demonstrate that specific BRCA2 PSVs may be associated with elevated risk of developing aggressive prostate cancer. Significance: Aggressive prostate cancer risk in BRCA2 mutation carriers may vary according to the specific BRCA2 mutation inherited by the at-risk individual.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.089
Threshold uncertainty score0.374

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.012
GPT teacher head0.320
Teacher spread0.308 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations52
Published2019
Admission routes2
Has abstractyes

Explore more

Same venueCancer ResearchSame topicBRCA gene mutations in cancerFrench-language works237,207